bpc-157 safety concerns fda warning not approved for human use fda warning bpc-157 unapproved peptide risk bpc-157 fda warning not approved FDA Compliance for Peptide Therapy and BPC- 157 – Holt Law-covingtoncountyhospital BPC-157: Experimental Peptide Creates Risk

Despite excellent protocol adherence, limitations include a small sample size potentially affecting power, confinement to a single center potentially limiting generalizability, and limited documentation of oral fluid intake due to emergency department management

It is strictly for research purposes and not for human consumption

Can repeat cycles depending on response, but not recommended for indefinite continuous use

A variety of factors can affect your results, including medication adherence, lifestyle habits such as diet and exercise, metabolic differences, other health conditions, and concurrent medications

It's worth noting that insurance may not cover these injections unless they're used to treat a specific medical condition